91¶¶Òù Platform
Answer any industry question in minutes with our entire database at your fingertips.
Veterinary Pharmaceutical and Medicinal Product Manufacturing in New Zealand Industry Data and Analysis
The Veterinary Pharmaceutical and Medicinal Product Manufacturing industry has recorded strong revenue growth over the past few years, despite unfavourable economic conditions and rising costs. To achieve this, manufacturers have pivoted towards high-value, specialised product ranges that command higher margins. Despite their higher prices, demand for these products has been robust, especially from livestock farms, which have become increasingly willing to pay premium prices to improve productivity. While falling discretionary incomes have led some consumers to opt for low-cost, generic companion animal treatments, pet humanisation trends have spurred demand for premium therapies, somewhat offsetting this trend. Overall, this has meant that industry revenue is expected to have grown at an annualised rate of 8.3% over the five years through 2026-27, including a 5.2% jump in the current year, to a total of $808.8 million. This has outpaced increases in key costs, like purchases and wages, resulting in higher profit margins for manufacturers during this period.
Access this data your way
The Veterinary Pharmaceutical and Medicinal Product Manufacturing in New Zealand Industry analysis is available in multiple formats to fit seamlessly into your workflow.
What's included in this industry analysis
91¶¶Òù's research coverage on the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand includes market sizing, forecasting, data and analysis from 2016-2031. The most recent publication was released August 2026.
About this industry
What's this industry report about?
The Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand operates under the ANZSIC industry code C1842NZ. The Veterinary Pharmaceutical and Medicinal Product Manufacturing industry has manufacturers that primarily manufacture drugs, medicines, medicinal chemicals, vaccines, serums and other pharmaceutical products for veterinary use. Related terms covered in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand include analgesics, anaesthetics, companion animal and dermatology.
What's included in this industry?
91¶¶Òù and services covered in Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand include Parasiticides, Vaccines and Antibiotics.
What companies are included in this industry?
Companies covered in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand include Schering-Plough Animal, Zoetis New Zealand and Virbac New Zealand.
Performance
What's included in the Performance chapter?
The Performance chapter covers detailed analysis, datasets, detailed current performance, sources of volatility and an outlook with forecasts for the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand.
Questions answered in this chapter include what's driving current industry performance, what influences industry volatility, how do successful businesses overcome volatility, what's driving the industry outlook. This analysis is supported with data and statistics on industry revenues, costs, profits, businesses and employees.
91¶¶Òù & Markets
What's included in the 91¶¶Òù and Markets chapter?
The 91¶¶Òù and Markets chapter covers detailed product and service segmentation, analysis of major markets and international trade data for the for the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand.
Questions answered in this chapter include how are the industry's products and services performing, what are innovations in industry products and services, what products or services do successful businesses offer and what's influencing demand from the industry's markets. This includes data and statistics on industry revenues by product and service segmentation and major markets.
Geographic Breakdown
What's included in the Geographic Breakdown chapter?
The Geographic Breakdown chapter covers detailed analysis and datasets on regional performance of the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand.
Questions answered in this chapter include where are industry businesses located and how do businesses use location to their advantage. This includes data and statistics on industry revenues by location.
Competitive Forces
What's included in the Competitive Forces chapter?
The Competitive Forces chapter covers the concentration, barriers to entry and supplier and buyer profiles in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand. This includes data and statistics on industry market share concentration, barriers to entry, substitute products and buyer & supplier power.
Questions answered in this chapter include what impacts the industry's market share concentration, how do successful businesses handle concentration, what challenges do potential industry entrants face, how can potential entrants overcome barriers to entry, what are substitutes for industry services, how do successful businesses compete with substitutes and what power do buyers and suppliers have over the industry and how do successful businesses manage buyer & supplier power.
Companies
What's included in the Companies chapter?
The Companies chapter covers Key Takeaways, Market Share and Companies in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand. This includes data and analysis on companies operating in the industry that hold a market share greater than 5%.
Questions answered in this chapter include what companies have a meaningful market share and how each company is performing.
External Environment
What's included in the External Environment chapter?
The External Environment chapter covers Key Takeaways, External Drivers, Regulation & Policy and Assistance in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand. This includes data and statistics on factors impacting industry revenue such as economic indicators, regulation, policy and assistance programs.
Questions answered in this chapter include what demographic and macroeconomic factors impact the industry, what regulations impact the industry, what assistance is available to this industry.
Financial Benchmarks
What's included in the Financial Benchmarks chapter?
The Financial Benchmarks chapter covers Key Takeaways, Cost Structure, Financial Ratios, Valuation Multiples and Key Ratios in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand. This includes financial data and statistics on industry performance including key cost inputs, profitability, key financial ratios and enterprise value multiples.
Questions answered in this chapter include what trends impact industry costs and how financial ratios have changed overtime.
Industry Data
What's included in the Industry Data chapter?
The Industry Data chapter includes 10 years of historical data with 5 years of forecast data covering statistics like revenue, industry value add, establishments, enterprises, employment and wages in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand.
Trusted by industry professionals
More than 6,000 businesses use 91¶¶Òù to shape local and global economies
We were able to supplement our reports with 91¶¶Òù¡¯s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of 91¶¶Òù integration.
91¶¶Òù delivers the crisp business knowledge we need to drive our business.? Whether it be serving up our major clients, winning new business or educating? on industry issues, 91¶¶Òù brings real value.
91¶¶Òù has revolutionised business information ¡ª which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you¡¯re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they¡¯re going to trust you a lot more.
Frequently Asked Questions
What is the market size of the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand in 2026?
The market size of the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand is $808.8m in 2026.
How many businesses are there in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand in 2026?
There are 46 businesses in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand, which has grown at a CAGR of 5.0 % between 2021 and 2026.
How may import tariffs affect the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand?
The Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand is likely to be impacted by import tariffs with imports accounting for a moderate share of industry revenue.
How may export tariffs affect the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand?
The Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand is likely to be impacted by export tariffs with exports accounting for a moderate share of industry revenue.
Has the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand grown or declined over the past 5 years?
The market size of the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand has been growing at a CAGR of 8.3 % between 2021 and 2026.
What is the forecast growth of the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand over the next 5 years?
Over the next five years, the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand is expected to grow.
What are the biggest companies in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand?
The biggest companies operating in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand are Schering-Plough Animal, Zoetis New Zealand and Virbac New Zealand
What does the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand include?
Parasiticides manufacturing and Immunotherapy product manufacturing (including vaccines) are part of the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand.
Which companies have the highest market share in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand?
The company holding the most market share in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand is Schering-Plough Animal.
How competitive is the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand?
The level of competition is moderate and increasing in the Veterinary Pharmaceutical and Medicinal Product Manufacturing industry in New Zealand.
Cut through the noise with intelligence you can trust
